Text Size
87 studies found for:    Open Studies | "Osteosarcoma"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma
Conditions: Metastatic Osteosarcoma;   Relapsed Osteosarcoma
Interventions: Drug: Sorafenib;   Drug: Everolimus
2 Recruiting Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Intervention: Other: laboratory biomarker analysis
3 Recruiting Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
Conditions: Osteosarcoma;   Metastatic Osteosarcoma
Intervention: Drug: pazopanib
4 Recruiting Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
Conditions: Bone Cancer;   Chondrosarcoma;   Ewing's Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma
Interventions: Drug: Feraheme;   Procedure: MR Scan
5 Recruiting A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Chemotherapy;   Drug: Endostar
6 Recruiting Diffusion Study on Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention:
7 Unknown † Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: High Dose Methotrexate
8 Recruiting Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Zoledronic acid;   Drug: Standard chemotherapy
9 Recruiting Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
Condition: Pulmonary Relapse of Osteosarcoma
Intervention: Drug: Inhaled Lipid Cisplatin (ILC)
10 Not yet recruiting Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Radiation: heavy ion radiotherapy (C12)
11 Unknown † Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma
Condition: Osteosarcoma
Interventions: Dietary Supplement: Curcumin powder;   Dietary Supplement: Ashwagandha extract
12 Recruiting Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Conditions: Osteosarcoma;   Nephrotoxicity;   Ototoxicity
Interventions: Drug: Pantoprazole;   Drug: High-dose methotrexate infusion duration
13 Recruiting Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Conditions: Adult Alveolar Soft-part Sarcoma;   Adult Angiosarcoma;   Adult Desmoplastic Small Round Cell Tumor;   Adult Epithelioid Hemangioendothelioma;   Adult Epithelioid Sarcoma;   Adult Extraskeletal Chondrosarcoma;   Adult Extraskeletal Osteosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Liposarcoma;   Adult Malignant Fibrous Histiocytoma;   Adult Malignant Mesenchymoma;   Adult Neurofibrosarcoma;   Adult Rhabdomyosarcoma;   Adult Synovial Sarcoma;   Chondrosarcoma;   Clear Cell Sarcoma of the Kidney;   Conjunctival Kaposi Sarcoma;   Dermatofibrosarcoma Protuberans;   Gastrointestinal Stromal Tumor;   Metastatic Adult Malignant Fibrous Histiocytoma of Bone;   Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Metastatic Osteosarcoma;   Ovarian Sarcoma;   Recurrent Adult Malignant Fibrous Histiocytoma of Bone;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Kaposi Sarcoma;   Recurrent Osteosarcoma;   Recurrent Uterine Sarcoma;   Small Intestine Leiomyosarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Uterine Sarcoma
Interventions: Drug: vismodegib;   Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097;   Other: laboratory biomarker analysis;   Other: pharmacological study
14 Recruiting ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Chemotherapy for positive p-glycoprotein expression;   Other: Chemotherapy for negative p-glycoprotein expression
15 Recruiting Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients
Condition: Osteosarcoma
Intervention:
16 Recruiting A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Condition: Osteosarcoma
Interventions: Drug: Saracatinib;   Drug: Placebo
17 Recruiting Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Mifamurtide
18 Not yet recruiting Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Lithium Carbonate
19 Recruiting Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Thiotepa
20 Recruiting Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults
Conditions: Ewing Sarcoma;   Osteosarcoma
Intervention: Other: MRI
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years